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INTRODUCTION 
The importance of trastuzumab (Tr) conjugation with bifunctional chelators (BFCs) in 
different molar ratio are presented with this study. A successful radiolabeling can be 
achieved after binding of optimal number of BFCs (4-5) per monoclonal antibody (mAb). 
The aim of our examination is to show that using a different BFCs in different molar ratio (p-
SCN-Bn-DTPA – 1:10, 1:20, 1:50; p-SCN-Bn-DOTA – 1:20; p-SCN-Bn-1B4M-DTPA – 1:10, 
1:20, 1:50) will achieve enough binding of the BFCs to Tr and formulation of 
immunoconjugates for further radiolabeling.  
MATERIAL AND METHODS 
IR physical mixture and 
inclusion complex. 
RESULTS CONCLUSION 
Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry (MALDI-
TOF MS) was employed for determination of average number of BFCs. Resuspension 
solution (30% ACN/70% 0.1 TFA) was added to the samples and an aliquot of 1 μl of the 
final sample was applied to the well plate template and mixed with 1 μl of matrix (20 
mg/ml Sinapinic acid in 50% ACN/50% 0.1 TFA). Acquisition mass range of the 
instrument is 100-300000 Da. 
An optimal number of BFCs were calculated in 
all samples. There was no significant 
difference in the number of the attached 
chelating groups by higher excess of the 
chelators: p-SCN-Bn-DTPA-Tr [1:10 (5 
groups); 1:20 (4.8 groups); 1:50 (5.3 groups)]; 
p-SCN-Bn-DOTA-Tr 1:20 (4.9 groups); p-SCN-
Bn-1B4M-DTPA [1:10 (4.9 groups); 1:20 (4.5 
groups); 1:50 (4.3 groups)]. 
MALDI-TOF MS calculations 
have shown successful 
conjugations and formulated 
immunoconjugates are 
protentional compounds for 
further 90Y and 177Lu 
radiolabeling. 
